Navigation Links
$3.35 Million Awarded in First Transvaginal Mesh Trial Verdict: Prompts McDonaldWorley.com Support Expansion
Date:2/26/2013

Houston, TX (PRWEB) February 26, 2013

The resulting verdict in the nations first pelvic mesh trial has prompted national law firm McDonaldWorley.com to expand the free legal reviews being provided to women who suffered complications. Attorneys with the firm emboldened by the $3.35 million compensation awarded for her past and future pain and suffering, medical costs and lost wages feel claims are strong for women who suffered problems (Gross v. Gynecare Inc., Atl-L-6966-10).

In a 7-2 vote a New Jersey state jury has dealt a blow to manufacturer Johnson & Johnson and its subsidiary in the first case to go to trial.

The jury in the landmark Atlantic City Superior Court case decided Feb. 25, according to HarrisMartin.com, found that the implanting surgeon for the plaintiff, Linda Gross, did not adequately warn of the risks associated with implanting the mesh and that the device was the proximate cause of injury. The judge is conducting a hearing to determine whether she will allow an award for punitive damages.

"The verdict signals to other women that suffered problems that they are not alone, that their needs will not be ignored. It's vital women contact us now to get their questions answered," stated Michelle R. Eddington, lead attorney with the firm.

In addition to helping people understand their legal options, the firm can help victims get funding for revision surgery to remove and repair damage caused if they don't have insurance or other means to pay for the surgery. Women are encouraged to ask for more information about financing options for corrective surgery.

The use of synthetic mesh for repair surgeries has been under scrutiny over the last three years. The FDA, having receiving thousands of reports of adverse effects, issued a health advisory warning in October 2008 to physicians considering transvaginal repair surgeries for their patients.

Dr. Margolis was quoted recently in CommonHealth.org as telling the FDA advisory panel that the use of these implants, "defies core surgical doctrines." and further mesh used in tissue repair procedures has been associated with a number of serious risks including wandering, erosion, infection, pain and perforations.

"Women should know that they are not alone, and that we are standing-by ready to ensure their needs are not ignored," added Ms. Eddington.

About McDonaldWorley.com:
Case evaluations are completely secure, 100% confidential, and being offered for women who have had surgical mesh surgery or family members.

To get information and answers from a real lawyer, click here: http://www.mcdonaldworley.com/transvaginal-mesh-lawyer.htm

Read the full story at http://www.prweb.com/releases/2013/2/prweb10467889.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NYU Langone Medical Center receives $17 million gift from the Steven A. and Alexandra M. Cohen Foundation
2. NIH awards $12.4 million grant to fund Henry Ford Hospital hypertension research
3. RWJF awards $1.9 million grant to PatientsLikeMe to create open research platform
4. Solid State (Smart) Transformer Market is expected to reach $5,043.39 million at a CAGR of 82.3% by 2020 - New Report by MarketsandMarkets
5. WUSTL researcher gets $2.25 million grant to better understand traumatic brain injury
6. NAS receives $3.5 million gift to establish Prize in Psychological and Cognitive Sciences
7. Dr. Lewis Cantley awarded $3 million breakthrough prize in life sciences
8. UC San Diego cancer scientist wins $3 million award
9. Flame Retardant Chemicals Market growing at a CAGR of 6.9% & to reach $7,131.9 Million by 2017 - New Report by MarketsandMarkets
10. Millions of Americans Have an STD: Report
11. Chris Guedri, of the Law Firm of Allen & Allen, Wins Case Against Food Lion and Ties for Largest Verdict in Gloucester County History: $5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: